anmelden
OMX Copenhagen 20
1.617,31
PKT
-3,75
PKT
-0,23
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Copenhagen 20-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.07.21 | Novo Nordisk Overweight | Barclays Capital | |
| 12.07.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 07.07.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.06.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 28.06.21 | Novo Nordisk Neutral | UBS AG | |
| 28.06.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 24.06.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 24.06.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 15.06.21 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.06.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.06.21 | Novo Nordisk Outperform | Bernstein Research | |
| 10.06.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.06.21 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 01.06.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 24.05.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 21.05.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 19.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 13.05.21 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
| 12.05.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.05.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 06.05.21 | Novo Nordisk Neutral | Credit Suisse Group | |
| 06.05.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 06.05.21 | A.P. Moeller - Maersk A-S (B) buy | Deutsche Bank AG | |
| 06.05.21 | A.P. Moeller - Maersk A-S (B) overweight | JP Morgan Chase & Co. | |
| 06.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.05.21 | Novo Nordisk overweight | Barclays Capital | |
| 05.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.05.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.04.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 28.04.21 | A.P. Moeller - Maersk A-S (B) buy | Deutsche Bank AG | |
| 14.04.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 13.04.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 25.03.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 23.03.21 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 23.03.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 23.03.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.03.21 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 16.03.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 10.03.21 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 05.03.21 | Novo Nordisk buy | Deutsche Bank AG |
